BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10482111)

  • 21. Lenalidomide: a new treatment option for Castleman disease.
    Szturz P; Adam Z; Chovancová J; Stehlíková O; Klabusay M; Rehák Z; Koukalová R; Krejčí M; Pour L; Zahradová L; Hájek R; Mayer J
    Leuk Lymphoma; 2012 Oct; 53(10):2089-91. PubMed ID: 21902577
    [No Abstract]   [Full Text] [Related]  

  • 22. Extranodal Castleman disease of the extremities: a case report and review of the literature.
    Eward WC; DeWitt SB; Brigman BE; Kontogeorgakos V; Lagoo AS
    Skeletal Radiol; 2014 Nov; 43(11):1627-31. PubMed ID: 24970669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Castleman Disease of the Parotid Gland: A Case Report.
    Xiao-Dong L; Qiu-Xu W; Wei-Xian L
    J Oral Maxillofac Surg; 2020 Mar; 78(3):400.e1-400.e6. PubMed ID: 31837286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
    Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
    J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports.
    Caroline Ribeiro Sales A; Romão de Souza Junior V; Iglis de Oliveira M; Azevedo Braga Albuquerque C; de Barros Campelo Júnior E; Sérgio Ramos de Araújo P
    J Med Case Rep; 2018 May; 12(1):117. PubMed ID: 29728131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentric Castleman disease presenting as a chylous pleural effusion.
    Epstein D; Zohar Y; Ovadya D; Ammouri H; Kremer R; Lavi N; Tzoran I; Andrawas ER; Klein E; Miller A
    Pathol Res Pract; 2020 Nov; 216(11):153209. PubMed ID: 32950896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated upper eyelid retraction: a sign of idiopathic inflammatory orbital disease.
    Shome D; Toshniwal S; Jain V; Natarajan S; Vemuganti GK
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):58-60. PubMed ID: 18209649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like features.
    Togitani K; Iguchi M; Asagiri T; Ogasawara F; Murakami I; Kojima K
    J Clin Exp Hematop; 2022 Mar; 62(1):46-51. PubMed ID: 34707036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A transitional variant of Castleman's disease presenting as a chylous pleural effusion.
    Ten Hoor T; Hewan-Lowe K; Miller JI; Moss M
    Chest; 1999 Jan; 115(1):285-8. PubMed ID: 9925102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever.
    Dunn R; Jariwal R; Venter F; Mishra S; Bhandohal J; Cobos E; Heidari A
    J Investig Med High Impact Case Rep; 2022; 10():23247096221097526. PubMed ID: 35549932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic inflammatory pseudotumor of the eyelid.
    Abrishami M; Bagheri A; Salour H; Aletaha M; Abrishami A; Parsafar H; Torbati P
    Ophthalmic Plast Reconstr Surg; 2010; 26(1):64-6. PubMed ID: 20090498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Castleman disease of the neck: A case report.
    Pasha H; Siddiqui MI; Wasif M
    J Pak Med Assoc; 2020 Feb; 70(2):354-356. PubMed ID: 32063646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
    Chen H; Ba W; Chen H; Yang H
    J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset skin involvement on the forehead in multicentric Castleman disease.
    Sato K; Shinkuma S; Fujimoto K; Hatanaka KC; Ujiie H; Nomura T; Fujita Y; Abe R; Matsuno Y; Shimizu H
    Int J Dermatol; 2017 Jul; 56(7):e152-e153. PubMed ID: 28244070
    [No Abstract]   [Full Text] [Related]  

  • 35. Idiopathic multicentric Castleman disease of TAFRO subtype.
    Godfrey K; Harris E; Moss H; Martin-Cabrera P
    Br J Haematol; 2022 Feb; 196(3):461. PubMed ID: 34618353
    [No Abstract]   [Full Text] [Related]  

  • 36. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
    Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
    Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unifocal cervical Castleman disease in two children.
    Tuerlinckx D; Bodart E; Delos M; Remacle M; Ninane J
    Eur J Pediatr; 1997 Sep; 156(9):701-3. PubMed ID: 9296533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraorbital haematoma during a commercial flight: a case report.
    Mete A; Pamukcu C; Mete A; Kimyon S; Mete D; Gözen İ; Saygılı O
    BMC Ophthalmol; 2015 May; 15():47. PubMed ID: 25946992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of unicentric Castleman disease with neoadjuvant rituximab.
    Bandera B; Ainsworth C; Shikle J; Rupard E; Roach M
    Chest; 2010 Nov; 138(5):1239-41. PubMed ID: 21051400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting idiopathic multicentric Castleman's disease.
    Dupin N
    Lancet Haematol; 2016 Apr; 3(4):e153-4. PubMed ID: 27063968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.